Radim Nencka

3.6k total citations
90 papers, 2.4k citations indexed

About

Radim Nencka is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Radim Nencka has authored 90 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 20 papers in Infectious Diseases and 16 papers in Epidemiology. Recurrent topics in Radim Nencka's work include Mosquito-borne diseases and control (16 papers), interferon and immune responses (11 papers) and Biochemical and Molecular Research (11 papers). Radim Nencka is often cited by papers focused on Mosquito-borne diseases and control (16 papers), interferon and immune responses (11 papers) and Biochemical and Molecular Research (11 papers). Radim Nencka collaborates with scholars based in Czechia, United States and Belgium. Radim Nencka's co-authors include Evžen Bouřa, Jan Šilhán, Daniel Růžek, Michal Šála, Luděk Eyer, Hubert Hřebabecký, Erik De Clercq, Petra Krafčíková, Milan Dejmek and Dominika Chalupská and has published in prestigious journals such as Nucleic Acids Research, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Radim Nencka

88 papers receiving 2.4k citations

Peers

Countries citing papers authored by Radim Nencka

Since Specialization

Citations

This map shows the geographic impact of Radim Nencka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radim Nencka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radim Nencka more than expected).

Fields of papers citing papers by Radim Nencka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radim Nencka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radim Nencka. The network helps show where Radim Nencka may publish in the future.

Co-authorship network of co-authors of Radim Nencka

This figure shows the co-authorship network connecting the top 25 collaborators of Radim Nencka. A scholar is included among the top collaborators of Radim Nencka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radim Nencka. Radim Nencka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors based on adenosine 5′-carboxamides 2024 ·RSC Medicinal Chemistry ·(unknown), Dominika Chalupská, Milan Dejmek, (unknown), (unknown), Michal Šála, Karel Chalupský, Petra Krafčíková, (unknown), (unknown), Eliška Procházková, Blanka Klepetářová, (unknown), (unknown), Helena Mertlíková‐Kaiserová, Evžen Bouřa, Jan Weber, Radim Nencka	5
2	Novel analogues of a nonnucleoside SARS-CoV-2 RdRp inhibitor as potential antivirotics 2024 ·Beilstein Journal of Organic Chemistry ·(unknown), (unknown), Milan Dejmek, (unknown), Blanka Klepetářová, Lenka Poštová Slavětínská, Evžen Bouřa, Radim Nencka	3
3	Structure–activity relationship study of small-molecule inhibitor of Atg12-Atg3 protein–protein interaction 2024 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), (unknown), Shani Bialik, Sílvia Carvalho, Noga Kozer, Haim Barr, (unknown), Adi Kimchi, Radim Nencka	2
4	Vinylphosphonate-based cyclic dinucleotides enhance STING-mediated cancer immunotherapy 2023 ·European Journal of Medicinal Chemistry ·Milan Dejmek, Andrea Brázdová, (unknown), (unknown), Martin Klíma, (unknown), (unknown), Miloš Buděšı́nský, Martin Dračínský, Radek Liboska, Evžen Bouřa, (unknown), Radim Nencka	8
5	Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping 2023 ·Journal of Medicinal Chemistry ·(unknown), Eva Řezníčková, (unknown), Radek Jorda, Milan Dejmek, (unknown), Michal Šála, (unknown), Martin Dračínský, (unknown), (unknown), (unknown), Karel Chalupský, (unknown), Tomáš Gucký, Helena Mertlíková‐Kaiserová, Pavel Klener, Radim Nencka, Vladimı́r Kryštof	8
6	Discovery of Novel Human Constitutive Androstane Receptor Agonists with the Imidazo[1,2-a]pyridine Structure 2023 ·Journal of Medicinal Chemistry ·(unknown), Ján Dušek, (unknown), (unknown), (unknown), Karel Chalupský, (unknown), Ivona Pávková, Thales Kronenberger, (unknown), (unknown), (unknown), Tomáš Smutný, Petr Pávek, Radim Nencka	13
7	Reactivation of the G1 enhancer landscape underlies core circuitry addiction to SWI/SNF 2023 ·Nucleic Acids Research ·Kateřina Čermáková, Ling Tao, Milan Dejmek, Michal Šála, (unknown), Yuen San Chan, (unknown), (unknown), (unknown), (unknown), Ronald J. Parchem, Wenyi Wang, Radim Nencka, Eveline Barbieri, H. Courtney Hodges	5
8	Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase Inhibitors 2023 ·ACS Omega ·(unknown), Dominika Chalupská, Karel Chalupský, (unknown), (unknown), Petra Krafčíková, (unknown), Michal Šála, Milan Dejmek, (unknown), (unknown), Jaroslav Kozák, (unknown), Masoud Vedadi, Jan Weber, Helena Mertlíková‐Kaiserová, Radim Nencka	13
9	Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase 2023 ·Nature Communications ·Jan Šilhán, Martin Klíma, (unknown), (unknown), Dominika Chalupská, Karel Chalupský, (unknown), Radim Nencka, Evžen Bouřa	29
10	SWI/SNF Blockade Disrupts PU.1-Directed Enhancer Programs in Normal Hematopoietic Cells and Acute Myeloid Leukemia 2023 ·Cancer Research ·(unknown), Kateřina Čermáková, Yuen San Chan, (unknown), (unknown), (unknown), (unknown), (unknown), Milan Dejmek, Michal Šála, (unknown), (unknown), Radim Nencka, H. Daniel Lacorazza, Rachel E. Rau, H. Courtney Hodges	21
11	Exploring positions 6 and 7 of a quinazoline-based scaffold leads to changes in selectivity and potency towards RIPK2/3 kinases 2023 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Kamil Hercík, (unknown), Dominika Chalupská, Milan Dejmek, Michal Šála, Miroslav Hájek, Evžen Bouřa, Helena Mertlíková‐Kaiserová, Radim Nencka	1
12	Structure-based design and modular synthesis of novel PI4K class II inhibitors bearing a 4-aminoquinazoline scaffold 2022 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Martin Klíma, (unknown), Dominika Chalupská, Milan Dejmek, Michal Šála, Helena Mertlíková‐Kaiserová, Evžen Bouřa, Radim Nencka	5
13	Ligand Strain and Its Conformational Complexity Is a Major Factor in the Binding of Cyclic Dinucleotides to STING Protein 2021 ·Angewandte Chemie ·(unknown), Ondrej Gutten, Milan Dejmek, Milan Kožíšek, Thomas Evangelidis, Zahra Aliakbar Tehrani, (unknown), Radim Nencka, (unknown), Lubomı́r Rulı́šek, Evžen Bouřa	2
14	Ligand Strain and Its Conformational Complexity Is a Major Factor in the Binding of Cyclic Dinucleotides to STING Protein 2021 ·Angewandte Chemie International Edition ·(unknown), Ondrej Gutten, Milan Dejmek, Milan Kožíšek, Thomas Evangelidis, Zahra Aliakbar Tehrani, (unknown), Radim Nencka, (unknown), Lubomı́r Rulı́šek, Evžen Bouřa	28
15	Non-Nucleotide RNA-Dependent RNA Polymerase Inhibitor That Blocks SARS-CoV-2 Replication 2021 ·Viruses ·Milan Dejmek, Eva Konkoľová, Luděk Eyer, Petra Straková, Pavel Svoboda, Michal Šála, (unknown), Daniel Růžek, Evžen Bouřa, Radim Nencka	27
16	Synthesis and Biological Evaluation of Phosphoester and Phosphorothioate Prodrugs of STING Agonist 3′,3′-c-Di(2′F,2′dAMP) 2021 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Martin Kaiser, (unknown), Martin Dračínský, (unknown), Aleš Marek, Milan Dejmek, Michal Šála, Ondrej Gutten, Lubomı́r Rulı́šek, (unknown), Andrea Brázdová, Zlatko Janeba, Radim Nencka, Evžen Bouřa, Ondřej Páv, (unknown)	32
17	Remdesivir triphosphate can efficiently inhibit the RNA-dependent RNA polymerase from various flaviviruses 2020 ·Antiviral Research ·Eva Konkoľová, Milan Dejmek, Hubert Hřebabecký, Michal Šála, (unknown), Radim Nencka, Evžen Bouřa	48
18	Viral RNA-Dependent RNA Polymerase Inhibitor 7-Deaza-2′- C -Methyladenosine Prevents Death in a Mouse Model of West Nile Virus Infection 2019 ·Antimicrobial Agents and Chemotherapy ·Luděk Eyer, Martina Fojtíková, Radim Nencka, Ivo Rudolf, Zdeněk Hubálek, Daniel Růžek	25
19	Phosphatidylinositol 4-kinases: Function, structure, and inhibition 2015 ·Experimental Cell Research ·Evžen Bouřa, Radim Nencka	115
20	In Vivo 5FU-Exposed Human Medullary Thyroid Carcinoma Cells Contain a Chemoresistant CD133+ Tumor–Initiating Cell Subset 2013 ·Thyroid ·Lucia Kučerová, (unknown), Zuzana Kozovská, (unknown), Miroslava Matúšková, Radim Nencka, Pavel Babál	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact